Cable Hill Partners, LLC Omeros Corp Transaction History

Cable Hill Partners, LLC

  • $964 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 06, 2019
SELL
$15.0 - $19.62 $90,000 - $117,720
-6,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$17.73 - $26.69 $53,190 - $80,070
3,000 Added 100.0%
6,000 $85,000
Q1 2018

Apr 20, 2018
BUY
$9.0 - $20.16 $18,000 - $40,320
2,000 Added 200.0%
3,000 $41,000
Q4 2017

Feb 22, 2018
BUY
$13.26 - $22.86 $11,934 - $20,574
900 Added 900.0%
1,000 $20,000
Q3 2017

Oct 27, 2017
SELL
$19.76 - $24.9 $2,964 - $3,735
-150 Reduced 60.0%
100 $2,000
Q2 2017

Aug 14, 2017
BUY
N/A
250
250 $5,000

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $762M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email